Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 50Lymphoma 6Recurrence 3Waldenstrom Macroglobulinemia 2Plasmacytoma 2Leukemia, Plasma Cell 2Leukemia, Myeloid, Acute 2Immunoglobulin Light-chain Amyloidosis 2Hematologic Neoplasms 2Amyloidosis 2Smoldering Multiple Myeloma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1POEMS Syndrome 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Hematologic Diseases 1Graft vs Host Disease 1Glioblastoma 1Chromosome 17 deletion 1Alzheimer Disease 1Advanced Non-hematologic Malignancies 1Advanced Cancers 1

Interventions

ixazomib 1TAK 733 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Non-hematologic Malignancies × ixazomib × Clear all
NCT00830869 2019-09-09

A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies

Takeda

Phase 1 Completed
116 enrolled 33 charts

Advanced Non-hematologic Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡